$MMSI
MERIT MEDICAL SYSTEMS INC Stock $mmsi

$mmsi Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000085698224000015 Filed on February 28, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$323.5M	$324.5M	$1.257B
YoY Change	8.72%	10.6%	9.24%
Cost Of Revenue	$171.8M	$174.0M	$673.5M
YoY Change	7.91%	9.52%	6.59%
Gross Profit	$151.7M	$150.5M	$583.9M
YoY Change	9.65%	11.87%	12.48%
Gross Profit Margin	46.9%	46.39%	46.44%
Selling, General & Admin	$94.43M	$95.75M	$373.7M
YoY Change	4.75%	15.03%	9.09%
% of Gross Profit	62.24%	63.61%	64.0%
Research & Development	$21.48M	$21.64M	$82.73M
YoY Change	0.79%	5.89%	9.56%
% of Gross Profit	14.16%	14.38%	14.17%
Depreciation & Amortization	$23.60M	$23.63M	$89.99M
YoY Change	14.91%	15.29%	10.0%
% of Gross Profit	15.55%	15.7%	15.41%
Operating Expenses	$115.8M	$116.9M	$459.9M
YoY Change	3.41%	12.87%	6.58%
Operating Profit	$35.92M	$33.61M	$123.9M
YoY Change	36.16%	8.55%	41.55%
Interest Expense	$8.046M	-$3.054M	$15.51M
YoY Change	300.1%	50.0%	144.69%
% of Operating Profit	22.4%	-9.09%	12.51%
Other Income/Expense, Net	-$1.574M	$909.0K	-$11.86M
YoY Change	78.26%	-48.76%	140.27%
Pretax Income	$34.35M	$31.47M	$112.1M
YoY Change	34.7%	4.35%	35.65%
Income Tax	$6.108M	$3.838M	$17.68M
% Of Pretax Income	17.78%	12.2%	15.77%
Net Earnings	$28.24M	$27.63M	$94.41M
YoY Change	36.41%	-17.28%	26.7%
Net Earnings / Revenue	8.73%	8.51%	7.51%
Basic Earnings Per Share	$0.49		$1.64
Diluted Earnings Per Share	$0.48	$0.47	$1.62
COMMON SHARES
Basic Shares Outstanding	57.93M	57.75M	57.59M
Diluted Shares Outstanding	58.57M		58.36M

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$581.9M	$587.0M	$587.0M
YoY Change	904.26%	905.06%	905.06%
Cash & Equivalents	$581.9M	$587.0M	$587.0M
Short-Term Investments
Other Short-Term Assets	$28.53M	$28.30M	$28.30M
YoY Change	19.45%	7.87%	7.87%
Inventory	$302.7M	$303.9M	$303.9M
Prepaid Expenses
Receivables	$180.7M	$177.9M	$177.9M
Other Receivables	$11.43M	$11.38M	$11.38M
Total Short-Term Assets	$1.105B	$1.108B	$1.108B
YoY Change	98.36%	109.51%	109.51%
LONG-TERM ASSETS
Property, Plant & Equipment	$383.7M	$383.5M	$446.6M
YoY Change	-0.98%	0.14%	-0.37%
Goodwill	$381.5M	$382.2M
YoY Change	5.9%	6.23%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$58.68M	$54.79M	$58.84M
YoY Change	28.35%	23.54%	21.18%
Total Long-Term Assets	$1.221B	$1.217B	$1.217B
YoY Change	8.36%	7.22%	7.22%
TOTAL ASSETS
Total Short-Term Assets	$1.105B	$1.108B	$1.108B
Total Long-Term Assets	$1.221B	$1.217B	$1.217B
Total Assets	$2.326B	$2.325B	$2.325B
YoY Change	38.14%	39.74%	39.74%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$48.38M	$65.94M	$65.94M
YoY Change	-26.24%	-3.74%	-3.74%
Accrued Expenses	$113.2M	$120.4M	$132.1M
YoY Change	-5.01%	-2.23%	11.61%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$183.3M	$203.6M	$203.6M
YoY Change	-15.1%	-7.74%	-7.74%
LONG-TERM LIABILITIES
Long-Term Debt	$800.1M	$823.0M	$823.0M
YoY Change	329.2%	340.68%	340.68%
Other Long-Term Liabilities	$14.96M	$13.83M	$91.12M
YoY Change	7.6%	-6.15%	-2.76%
Total Long-Term Liabilities	$815.1M	$836.8M	$914.1M
YoY Change	306.89%	315.32%	225.94%
TOTAL LIABILITIES
Total Short-Term Liabilities	$183.3M	$203.6M	$203.6M
Total Long-Term Liabilities	$815.1M	$836.8M	$914.1M
Total Liabilities	$1.086B	$1.123B	$1.123B
YoY Change	111.95%	116.19%	116.19%
SHAREHOLDERS EQUITY
Retained Earnings	$603.4M	$575.2M
YoY Change	20.33%	19.64%
Common Stock	$649.2M	$638.2M
YoY Change	-4.68%	-5.48%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.240B	$1.202B	$1.202B
YoY Change
Total Liabilities & Shareholders Equity	$2.326B	$2.325B	$2.325B
YoY Change	38.14%	39.74%	39.74%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	$28.24M	$27.63M	$94.41M
YoY Change	36.41%	-17.28%	26.7%
Depreciation, Depletion And Amortization	$23.60M	$23.63M	$89.99M
YoY Change	14.91%	15.29%	10.0%
Cash From Operating Activities	$36.22M	$62.25M	$145.2M
YoY Change	148.99%	122.26%	27.0%
INVESTING ACTIVITIES
Capital Expenditures	$11.68M	$7.794M	$34.29M
YoY Change	-8.63%	-37.6%	-23.85%
Acquisitions	$3.346M		$138.3M
YoY Change	67.3%		1568.61%
Other Investing Activities	-$9.508M	-$549.0K	-$138.6M
YoY Change	359.1%	-88.65%	1021.01%
Cash From Investing Activities	-$22.05M	-$8.343M	-$175.3M
YoY Change	48.43%	-51.86%	205.5%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$15.58M
YoY Change			-22.35%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-18.00M	472.8M	559.3M
YoY Change	3522.33%	-8324.21%	-1028.09%
NET CHANGE
Cash From Operating Activities	36.22M	62.25M	145.2M
Cash From Investing Activities	-22.05M	-8.343M	-175.3M
Cash From Financing Activities	-18.00M	472.8M	559.3M
Net Change In Cash	-5.157M	526.7M	528.6M
YoY Change	1093.75%	10583.94%	-7449.64%
FREE CASH FLOW
Cash From Operating Activities	$36.22M	$62.25M	$145.2M
Capital Expenditures	$11.68M	$7.794M	$34.29M
Free Cash Flow	$24.53M	$54.46M	$110.9M
YoY Change	1293.98%	250.93%	60.06%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0000856982
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2021	us-gaap	Impairment Of Intangible Asset Finite Lived Statement Of Income Or Comprehensive Income Extensible Enumeration ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2023#AssetImpairmentCharges
CY2022	us-gaap	Impairment Of Intangible Asset Finite Lived Statement Of Income Or Comprehensive Income Extensible Enumeration ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2023#AssetImpairmentCharges
CY2023	us-gaap	Impairment Of Intangible Asset Finite Lived Statement Of Income Or Comprehensive Income Extensible Enumeration ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2023#AssetImpairmentCharges
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q4	us-gaap	Restricted Cash Current Asset Statement Of Financial Position Extensible List RestrictedCashCurrentAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#PrepaidExpenseAndOtherAssetsCurrent
CY2023Q4	us-gaap	Restricted Cash Current Asset Statement Of Financial Position Extensible List RestrictedCashCurrentAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#PrepaidExpenseAndOtherAssetsCurrent
CY2023	dei	Entity Registrant Name EntityRegistrantName	MERIT MEDICAL SYSTEMS INC
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	57306000
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	57858000
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents Current Asset Statement Of Financial Position Extensible List RestrictedCashAndCashEquivalentsCurrentAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#PrepaidExpenseAndOtherAssetsCurrent
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	0-18592
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	UT
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	87-0447695
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	1600 West Merit Parkway
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	South Jordan
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	UT
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	84095
CY2023	dei	City Area Code CityAreaCode	801
CY2023	dei	Local Phone Number LocalPhoneNumber	253-1600
CY2023	dei	Security12b Title Security12bTitle	Common Stock, no par value
CY2023	dei	Trading Symbol TradingSymbol	MMSI
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	false
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	4700000000
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	57930050
CY2023	dei	Auditor Name AuditorName	DELOITTE & TOUCHE LLP
CY2023	dei	Auditor Location AuditorLocation	Salt Lake City, Utah
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	587036000
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	58408000
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	9023000
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	8423000
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	177885000
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	164677000
CY2023Q4	us-gaap	Nontrade Receivables Current NontradeReceivablesCurrent	10517000
CY2022Q4	us-gaap	Nontrade Receivables Current NontradeReceivablesCurrent	12992000
CY2023Q4	us-gaap	Inventory Net InventoryNet	303871000
CY2022Q4	us-gaap	Inventory Net InventoryNet	265991000
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	24286000
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	22324000
CY2023Q4	us-gaap	Prepaid Taxes PrepaidTaxes	4016000
CY2022Q4	us-gaap	Prepaid Taxes PrepaidTaxes	3913000
CY2023Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	859000
CY2022Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	779000
CY2023Q4	us-gaap	Assets Current AssetsCurrent	1108470000
CY2022Q4	us-gaap	Assets Current AssetsCurrent	529084000
CY2023Q4	us-gaap	Land Land	26017000
CY2022Q4	us-gaap	Land Land	25940000
CY2023Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	191491000
CY2022Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	189148000
CY2023Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	316930000
CY2022Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	299089000
CY2023Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	63044000
CY2022Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	61128000
CY2023Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	53638000
CY2022Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	49673000
CY2023Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	61439000
CY2022Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	61269000
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	712559000
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	686247000
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	329036000
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	303271000
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	383523000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	382976000
CY2023Q4	us-gaap	Goodwill Goodwill	382240000
CY2022Q4	us-gaap	Goodwill Goodwill	359821000
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	7288000
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	6599000
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	63047000
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	65262000
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	54793000
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	44352000
CY2023Q4	mmsi	Intangible Assets Net Goodwill And Other Assets Noncurrent IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrent	833251000
CY2022Q4	mmsi	Intangible Assets Net Goodwill And Other Assets Noncurrent IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrent	751906000
CY2023Q4	us-gaap	Assets Assets	2325244000
CY2022Q4	us-gaap	Assets Assets	1663966000
CY2023Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	65944000
CY2022Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	68504000
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	120447000
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	123189000
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	11250000
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	12087000
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	11005000
CY2023Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	5086000
CY2022Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	6697000
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	203564000
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	220645000
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	823013000
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	186759000
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	5547000
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	18462000
CY2023Q4	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	347000
CY2022Q4	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	347000
CY2023Q4	us-gaap	Liability For Uncertain Tax Positions Noncurrent LiabilityForUncertainTaxPositionsNoncurrent	1912000
CY2022Q4	us-gaap	Liability For Uncertain Tax Positions Noncurrent LiabilityForUncertainTaxPositionsNoncurrent	1912000
CY2023Q4	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	17167000
CY2022Q4	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	15264000
CY2023Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	1605000
CY2022Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	1708000
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	56259000
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	59736000
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	13830000
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	14736000
CY2023Q4	us-gaap	Liabilities Liabilities	1123244000
CY2022Q4	us-gaap	Liabilities Liabilities	519569000
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	57858000
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	57306000
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	638150000
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	675174000
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	575184000
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	480773000
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-11334000
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-11550000
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	1202000000
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	1144397000
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2325244000
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1663966000
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1257366000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1150981000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1074751000
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	673494000
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	631882000
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	589418000
CY2023	us-gaap	Gross Profit GrossProfit	583872000
CY2022	us-gaap	Gross Profit GrossProfit	519099000
CY2021	us-gaap	Gross Profit GrossProfit	485333000
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	373676000
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	342525000
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	335690000
CY2023	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	82728000
CY2022	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	75510000
CY2021	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	71247000
CY2021	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	10036000
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	270000
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	2219000
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	4283000
CY2023	mmsi	Business Combination Contingent Consideration Arrangements Contingent Consideration Benefit BusinessCombinationContingentConsiderationArrangementsContingentConsiderationBenefit	-1704000
CY2022	mmsi	Business Combination Contingent Consideration Arrangements Contingent Consideration Benefit BusinessCombinationContingentConsiderationArrangementsContingentConsiderationBenefit	-4611000
CY2021	mmsi	Business Combination Contingent Consideration Arrangements Contingent Consideration Benefit BusinessCombinationContingentConsiderationArrangementsContingentConsiderationBenefit	-3161000
CY2023	us-gaap	Research And Development Asset Acquired Other Than Through Business Combination Written Off ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff	1550000
CY2022	us-gaap	Research And Development Asset Acquired Other Than Through Business Combination Written Off ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff	6671000
CY2023	us-gaap	Operating Expenses OperatingExpenses	459928000
CY2022	us-gaap	Operating Expenses OperatingExpenses	431536000
CY2021	us-gaap	Operating Expenses OperatingExpenses	424417000
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	123944000
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	87563000
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	60916000
CY2023	us-gaap	Investment Income Net InvestmentIncomeNet	2456000
CY2022	us-gaap	Investment Income Net InvestmentIncomeNet	439000
CY2021	us-gaap	Investment Income Net InvestmentIncomeNet	769000
CY2023	us-gaap	Interest Expense InterestExpense	15511000
CY2022	us-gaap	Interest Expense InterestExpense	6339000
CY2021	us-gaap	Interest Expense InterestExpense	5261000
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1200000
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	966000
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2507000
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-11855000
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-4934000
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-6999000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	112089000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	82629000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	53917000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	17678000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	8113000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5463000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	94411000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	74516000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	48454000
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.64
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.31
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.86
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.62
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.29
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.84
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	57593000
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	56806000
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	56145000
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	58356000
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	57671000
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	57359000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	94411000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	74516000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	48454000
CY2023	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Before Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent	-3570000
CY2022	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Before Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent	9007000
CY2021	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Before Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent	5965000
CY2023	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent	-866000
CY2022	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent	2177000
CY2021	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent	1489000
CY2023	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax	2959000
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax	-10491000
CY2021	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax	-7704000
CY2023	us-gaap	Other Comprehensive Income Foreign Currency Translation Gain Loss Arising During Period Tax OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax	39000
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Translation Gain Loss Arising During Period Tax OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax	-102000
CY2021	us-gaap	Other Comprehensive Income Foreign Currency Translation Gain Loss Arising During Period Tax OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax	-689000
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	216000
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-3559000
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-2539000
CY2023	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	94627000
CY2022	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	70957000
CY2021	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	45915000
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	958575000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	48454000
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-2539000
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	14579000
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	20374000
CY2021	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	1112000
CY2021	mmsi	Stock Surrendered During Period Value Payroll Tax Liabilities Stock Options Exercised StockSurrenderedDuringPeriodValuePayrollTaxLiabilitiesStockOptionsExercised	576000
CY2021	mmsi	Stock Surrendered During Period Value Stock Options Exercised StockSurrenderedDuringPeriodValueStockOptionsExercised	180000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	1039799000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	74516000
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-3559000
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	16045000
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	20092000
CY2022	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	1118000
CY2022	mmsi	Stock Surrendered During Period Value Payroll Tax Liabilities Stock Options Exercised StockSurrenderedDuringPeriodValuePayrollTaxLiabilitiesStockOptionsExercised	2474000
CY2022	mmsi	Stock Surrendered During Period Value Stock Options Exercised StockSurrenderedDuringPeriodValueStockOptionsExercised	1140000
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	1144397000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	94411000
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	216000
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	19043000
CY2023	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	20312000
CY2023	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	1081000
CY2023	mmsi	Equity Adjustments Purchase Of Capped Call Options EquityAdjustmentsPurchaseOfCappedCallOptions	-66528000
CY2023	mmsi	Stock Surrendered During Period Value Payroll Tax Liabilities Stock Options Exercised StockSurrenderedDuringPeriodValuePayrollTaxLiabilitiesStockOptionsExercised	5123000
CY2023	mmsi	Stock Surrendered During Period Value Stock Options Exercised StockSurrenderedDuringPeriodValueStockOptionsExercised	5809000
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	1202000000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	94411000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	74516000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	48454000
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	89985000
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	81804000
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	84066000
CY2023	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	431000
CY2022	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	-1417000
CY2023	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-5838000
CY2022	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-380000
CY2021	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-1303000
CY2023	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	506000
CY2022	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	2281000
CY2021	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	4412000
CY2023	us-gaap	Research And Development Asset Acquired Other Than Through Business Combination Written Off ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff	1550000
CY2022	us-gaap	Research And Development Asset Acquired Other Than Through Business Combination Written Off ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff	6671000
CY2023	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	11307000
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	10394000
CY2021	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	11718000
CY2023	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	1704000
CY2022	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	4611000
CY2021	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	3161000
CY2023	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	104000
CY2022	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	107000
CY2021	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	108000
CY2023	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1717000
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	604000
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	604000
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-12643000
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-14924000
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-4631000
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	21333000
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	18042000
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	16090000
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	11916000
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	15116000
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	8618000
CY2023	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-2429000
CY2022	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-4154000
CY2021	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	10418000
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	32105000
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	47929000
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	25183000
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1281000
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1798000
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3555000
CY2023	us-gaap	Increase Decrease In Prepaid Taxes IncreaseDecreaseInPrepaidTaxes	92000
CY2022	us-gaap	Increase Decrease In Prepaid Taxes IncreaseDecreaseInPrepaidTaxes	379000
CY2021	us-gaap	Increase Decrease In Prepaid Taxes IncreaseDecreaseInPrepaidTaxes	-125000
CY2023	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	58000
CY2022	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-1952000
CY2021	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-739000
CY2023	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	5976000
CY2022	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-657000
CY2021	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	1670000
CY2023	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-7297000
CY2022	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	12661000
CY2021	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	6050000
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-2484000
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-16379000
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	36462000
CY2023	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-1685000
CY2022	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	4521000
CY2021	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-119000
CY2022	mmsi	Increase Decrease Liability For Uncertain Tax Positions IncreaseDecreaseLiabilityForUncertainTaxPositions	-45000
CY2021	mmsi	Increase Decrease Liability For Uncertain Tax Positions IncreaseDecreaseLiabilityForUncertainTaxPositions	314000
CY2023	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	1903000
CY2022	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	-2848000
CY2021	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	1303000
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-11492000
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-11127000
CY2021	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-12410000
CY2023	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-2530000
CY2022	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	278000
CY2021	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-858000
CY2023	us-gaap	Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	50740000
CY2022	us-gaap	Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	39775000
CY2021	us-gaap	Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	98777000
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	145151000
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	114291000
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	147231000
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	34290000
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	45029000
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	27939000
CY2023	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	2411000
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	3175000
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	2834000
CY2023	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	201000
CY2022	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	65000
CY2021	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	1037000
CY2023	us-gaap	Proceeds From Divestiture Of Businesses Net Of Cash Divested ProceedsFromDivestitureOfBusinessesNetOfCashDivested	431000
CY2022	us-gaap	Proceeds From Divestiture Of Businesses Net Of Cash Divested ProceedsFromDivestitureOfBusinessesNetOfCashDivested	-971000
CY2021	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	2000000
CY2023	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	1000000
CY2021	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	2254000
CY2023	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	138278000
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	8287000
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	7171000
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-175347000
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-57397000
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-37161000
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	15584000
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	20070000
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	21306000
CY2023	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	1199203000
CY2022	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	215205000
CY2021	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	98421000
CY2023	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt	579624000
CY2022	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt	260143000
CY2021	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt	206921000
CY2023	us-gaap	Payments For Derivative Instrument Financing Activities PaymentsForDerivativeInstrumentFinancingActivities	66528000
CY2023	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	677000
CY2023	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	3569000
CY2022	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	32918000
CY2021	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	10665000
CY2023	mmsi	Payments Related To Tax Withholding For Exchange Of Common Stock PaymentsRelatedToTaxWithholdingForExchangeOfCommonStock	5123000
CY2022	mmsi	Payments Related To Tax Withholding For Exchange Of Common Stock PaymentsRelatedToTaxWithholdingForExchangeOfCommonStock	2474000
CY2021	mmsi	Payments Related To Tax Withholding For Exchange Of Common Stock PaymentsRelatedToTaxWithholdingForExchangeOfCommonStock	576000
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2
CY2023	mmsi	Number Of Product Categories NumberOfProductCategories	5
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	559266000
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-60260000
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-98435000
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-484000
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-3826000
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-801000
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	528586000
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-7192000
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	10834000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	60558000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	67750000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	56916000
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	589144000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	60558000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	67750000
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	587036000
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	58408000
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	67750000
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	2108000
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	2150000
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	589144000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	60558000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	67750000
CY2023	us-gaap	Interest Paid Capitalized InterestPaidCapitalized	1272000
CY2022	us-gaap	Interest Paid Capitalized InterestPaidCapitalized	858000
CY2021	us-gaap	Interest Paid Capitalized InterestPaidCapitalized	480000
CY2023	us-gaap	Interest Paid Net InterestPaidNet	14051000
CY2022	us-gaap	Interest Paid Net InterestPaidNet	6258000
CY2021	us-gaap	Interest Paid Net InterestPaidNet	5261000
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	31534000
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	17092000
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	8828000
CY2023	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	8267000
CY2022	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	3702000
CY2021	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	2558000
CY2023	mmsi	Acquisition Of Developed Technology In Accrued Expenses AcquisitionOfDevelopedTechnologyInAccruedExpenses	3713000
CY2022	mmsi	Acquisition Of Developed Technology In Accrued Expenses AcquisitionOfDevelopedTechnologyInAccruedExpenses	3526000
CY2023	mmsi	Stock Issued During Period Shares Treasury Stock Reissued Share Based Payment Arrangement StockIssuedDuringPeriodSharesTreasuryStockReissuedShareBasedPaymentArrangement	86000
CY2022	mmsi	Stock Issued During Period Shares Treasury Stock Reissued Share Based Payment Arrangement StockIssuedDuringPeriodSharesTreasuryStockReissuedShareBasedPaymentArrangement	18000
CY2021	mmsi	Stock Issued During Period Shares Treasury Stock Reissued Share Based Payment Arrangement StockIssuedDuringPeriodSharesTreasuryStockReissuedShareBasedPaymentArrangement	3000
CY2023	mmsi	Stock Surrendered During Period Value Stock Options Exercised StockSurrenderedDuringPeriodValueStockOptionsExercised	5809000
CY2022	mmsi	Stock Surrendered During Period Value Stock Options Exercised StockSurrenderedDuringPeriodValueStockOptionsExercised	1140000
CY2021	mmsi	Stock Surrendered During Period Value Stock Options Exercised StockSurrenderedDuringPeriodValueStockOptionsExercised	180000
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	8891000
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	11130000
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1524000
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Use of Estimates in Preparing Financial Statements</b>. The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2023Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	2100000
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	2100000
CY2023	us-gaap	Number Of Reporting Units NumberOfReportingUnits	4
CY2023	us-gaap	Depreciation Depreciation	34000000.0
CY2022	us-gaap	Depreciation Depreciation	33400000
CY2021	us-gaap	Depreciation Depreciation	34500000
CY2023Q4	us-gaap	Cash Surrender Value Of Life Insurance CashSurrenderValueOfLifeInsurance	18300000
CY2022Q4	us-gaap	Cash Surrender Value Of Life Insurance CashSurrenderValueOfLifeInsurance	15800000
CY2023Q4	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	17200000
CY2022Q4	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	15300000
CY2023Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	19061000
CY2022Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	15576000
CY2023Q4	us-gaap	Deferred Compensation Plan Assets DeferredCompensationPlanAssets	18309000
CY2022Q4	us-gaap	Deferred Compensation Plan Assets DeferredCompensationPlanAssets	15767000
CY2023Q4	us-gaap	Long Term Accounts Notes And Loans Receivable Net Noncurrent LongTermAccountsNotesAndLoansReceivableNetNoncurrent	3241000
CY2022Q4	us-gaap	Long Term Accounts Notes And Loans Receivable Net Noncurrent LongTermAccountsNotesAndLoansReceivableNetNoncurrent	2397000
CY2023Q4	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	14182000
CY2022Q4	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	10612000
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	54793000
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	44352000
CY2023Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	3039000
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	2260000
CY2023Q4	us-gaap	Other Long Term Debt OtherLongTermDebt	10791000
CY2022Q4	us-gaap	Other Long Term Debt OtherLongTermDebt	12476000
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	13830000
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	14736000
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	21300000
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	18000000.0
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	16100000
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1257366000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1150981000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1074751000
CY2023Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	158893000
CY2022Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	147051000
CY2023Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	25420000
CY2022Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	29534000
CY2023Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	119558000
CY2022Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	89406000
CY2023Q4	us-gaap	Inventory Net InventoryNet	303871000
CY2022Q4	us-gaap	Inventory Net InventoryNet	265991000
CY2022Q4	us-gaap	Goodwill Goodwill	359821000
CY2021Q4	us-gaap	Goodwill Goodwill	361741000
CY2023	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-883000
CY2022	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	1920000
CY2023	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	21536000
CY2023Q4	us-gaap	Goodwill Goodwill	382240000
CY2022Q4	us-gaap	Goodwill Goodwill	359821000
CY2022Q4	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	8300000
CY2023Q4	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	8300000
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	56100000
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	48400000
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	49600000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	62244000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	60127000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	49037000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	45619000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	44230000
CY2023	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	60935000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	77562000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	21328000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	51154000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	5067000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	32589000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	112089000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	82629000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	53917000
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	15684000
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	9584000
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	808000
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	3775000
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	3162000
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	806000
CY2023	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	10862000
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	10291000
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	8480000
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	30321000
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	23037000
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	10094000
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-11030000
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-10438000
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-468000
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-1699000
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-3615000
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-1845000
CY2023	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	86000
CY2022	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-871000
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-2318000
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-12643000
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-14924000
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-4631000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	17678000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	8113000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5463000
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	23539000
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	17352000
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	11323000
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	1627000
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	35000
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-283000
CY2023	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	2412000
CY2022	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	1978000
CY2021	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	2507000
CY2023	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-3994000
CY2022	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-10698000
CY2021	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-281000
CY2023	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	4000
CY2022	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	-47000
CY2021	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	401000
CY2023	us-gaap	Income Tax Reconciliation Tax Exempt Income IncomeTaxReconciliationTaxExemptIncome	548000
CY2022	us-gaap	Income Tax Reconciliation Tax Exempt Income IncomeTaxReconciliationTaxExemptIncome	-706000
CY2021	us-gaap	Income Tax Reconciliation Tax Exempt Income IncomeTaxReconciliationTaxExemptIncome	413000
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-3001000
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-3423000
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-5571000
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-90000
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	3523000
CY2023	mmsi	Effective Income Tax Rate Reconciliation Remeasurement Of State Deferred Taxes Amount EffectiveIncomeTaxRateReconciliationRemeasurementOfStateDeferredTaxesAmount	73000
CY2022	mmsi	Effective Income Tax Rate Reconciliation Remeasurement Of State Deferred Taxes Amount EffectiveIncomeTaxRateReconciliationRemeasurementOfStateDeferredTaxesAmount	375000
CY2021	mmsi	Effective Income Tax Rate Reconciliation Remeasurement Of State Deferred Taxes Amount EffectiveIncomeTaxRateReconciliationRemeasurementOfStateDeferredTaxesAmount	526000
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	2101000
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	2027000
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	2455000
CY2023	mmsi	Effective Income Tax Rate Reconciliation Remeasurement Of Contingent Consideration Liabilities Amount EffectiveIncomeTaxRateReconciliationRemeasurementOfContingentConsiderationLiabilitiesAmount	317000
CY2022	mmsi	Effective Income Tax Rate Reconciliation Remeasurement Of Contingent Consideration Liabilities Amount EffectiveIncomeTaxRateReconciliationRemeasurementOfContingentConsiderationLiabilitiesAmount	1061000
CY2021	mmsi	Effective Income Tax Rate Reconciliation Remeasurement Of Contingent Consideration Liabilities Amount EffectiveIncomeTaxRateReconciliationRemeasurementOfContingentConsiderationLiabilitiesAmount	733000
CY2023	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	208000
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-70000
CY2021	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	132000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	17678000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	8113000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5463000
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Returns And Allowances DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances	2009000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Returns And Allowances DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances	1925000
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation	10285000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation	9968000
CY2023Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	5477000
CY2022Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	5712000
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	10007000
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	11117000
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	7913000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	7167000
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Rent DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent	11331000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Rent DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent	12801000
CY2022Q4	mmsi	Deferred Tax Assets Federal Tax Credit Carryforwards Research DeferredTaxAssetsFederalTaxCreditCarryforwardsResearch	634000
CY2023Q4	mmsi	Deferred Tax Assets State Tax Credit Carryforwards Research DeferredTaxAssetsStateTaxCreditCarryforwardsResearch	5237000
CY2022Q4	mmsi	Deferred Tax Assets State Tax Credit Carryforwards Research DeferredTaxAssetsStateTaxCreditCarryforwardsResearch	4679000
CY2023Q4	mmsi	Deferred Tax Assets Capitalized Research And Development Expense DeferredTaxAssetsCapitalizedResearchAndDevelopmentExpense	26370000
CY2022Q4	mmsi	Deferred Tax Assets Capitalized Research And Development Expense DeferredTaxAssetsCapitalizedResearchAndDevelopmentExpense	15012000
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	10159000
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	8827000
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	88788000
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	77842000
CY2023Q4	us-gaap	Deferred Tax Liabilities Deferred Expense DeferredTaxLiabilitiesDeferredExpense	1123000
CY2022Q4	us-gaap	Deferred Tax Liabilities Deferred Expense DeferredTaxLiabilitiesDeferredExpense	1568000
CY2023Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	23539000
CY2022Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	20925000
CY2023Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	34613000
CY2022Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	38547000
CY2023Q4	mmsi	Deferred Tax Liabilities Foreign Withholding Tax DeferredTaxLiabilitiesForeignWithholdingTax	2005000
CY2022Q4	mmsi	Deferred Tax Liabilities Foreign Withholding Tax DeferredTaxLiabilitiesForeignWithholdingTax	1571000
CY2023Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	10129000
CY2022Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	11527000
CY2023Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	1898000
CY2022Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	2040000
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	73307000
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	76178000
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	13740000
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	13527000
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	1741000
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	11863000
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	7288000
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	6599000
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	5547000
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	18462000
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	1741000
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	11863000
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	213000
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	2700000
CY2021	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	573000
CY2023	us-gaap	Foreign Income Tax Expense Benefit Continuing Operations ForeignIncomeTaxExpenseBenefitContinuingOperations	434000
CY2022	us-gaap	Foreign Income Tax Expense Benefit Continuing Operations ForeignIncomeTaxExpenseBenefitContinuingOperations	320000
CY2021	us-gaap	Foreign Income Tax Expense Benefit Continuing Operations ForeignIncomeTaxExpenseBenefitContinuingOperations	288000
CY2022	mmsi	Income Tax Expense Benefit Restructuring Of Foreign Entities IncomeTaxExpenseBenefitRestructuringOfForeignEntities	-4300000
CY2023Q4	mmsi	Unrecognized Tax Benefits Gross Including Interest And Penalties UnrecognizedTaxBenefitsGrossIncludingInterestAndPenalties	1900000
CY2023Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	1900000
CY2022Q4	mmsi	Unrecognized Tax Benefits Gross Including Interest And Penalties UnrecognizedTaxBenefitsGrossIncludingInterestAndPenalties	1900000
CY2022Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	1900000
CY2022	mmsi	Uncertain Tax Positions Reduction Resulting From Liabilities For Non Current Deferred Income Tax Assets UncertainTaxPositionsReductionResultingFromLiabilitiesForNonCurrentDeferredIncomeTaxAssets	0
CY2023	mmsi	Uncertain Tax Positions Reduction Resulting From Liabilities For Non Current Deferred Income Tax Assets UncertainTaxPositionsReductionResultingFromLiabilitiesForNonCurrentDeferredIncomeTaxAssets	0
CY2023Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	290000
CY2022Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	336000
CY2023	mmsi	Uncertain Tax Positions Reduction Resulting From Liabilities For Unrecognized Tax Benefits UncertainTaxPositionsReductionResultingFromLiabilitiesForUnrecognizedTaxBenefits	-46000
CY2022	mmsi	Uncertain Tax Positions Reduction Resulting From Liabilities For Unrecognized Tax Benefits UncertainTaxPositionsReductionResultingFromLiabilitiesForUnrecognizedTaxBenefits	14000
CY2021	mmsi	Uncertain Tax Positions Reduction Resulting From Liabilities For Unrecognized Tax Benefits UncertainTaxPositionsReductionResultingFromLiabilitiesForUnrecognizedTaxBenefits	46000
CY2023Q4	us-gaap	Increase In Unrecognized Tax Benefits Is Reasonably Possible IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible	7000
CY2022Q4	mmsi	Advances From Employees Current AdvancesFromEmployeesCurrent	165000
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1576000
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1635000
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1674000
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	112000
CY2022	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	10000
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	82000
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	442000
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	294000
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	316000
CY2023	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	508000
CY2022	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	343000
CY2021	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	437000
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1622000
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1576000
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1635000
CY2023Q4	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	66929000
CY2022Q4	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	58620000
CY2023Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	408000
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	15813000
CY2023Q4	mmsi	Advances From Employees Current AdvancesFromEmployeesCurrent	285000
CY2023	us-gaap	Interest Expense InterestExpense	15511000
CY2023Q4	mmsi	Accrued Rebates Payable Current AccruedRebatesPayableCurrent	11005000
CY2022Q4	mmsi	Accrued Rebates Payable Current AccruedRebatesPayableCurrent	10925000
CY2022Q4	mmsi	Accrued Legal Settlement Current AccruedLegalSettlementCurrent	1000000
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	41820000
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	36666000
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	120447000
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	123189000
CY2023Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	23550000
CY2022Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	179000
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	823013000
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	198009000
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	11250000
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	823013000
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	186759000
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	99063000
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	747500000
CY2023Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	846563000
CY2023	mmsi	Line Of Credit Facility Covenant Terms Consolidates Senior Secured Net Leverage Ratio LineOfCreditFacilityCovenantTermsConsolidatesSeniorSecuredNetLeverageRatio	3.0
CY2023	mmsi	Threshold Number Of Consecutive Days Last Reported Sales Price Exceeding Percentage Of Conversion Price For Redemption ThresholdNumberOfConsecutiveDaysLastReportedSalesPriceExceedingPercentageOfConversionPriceForRedemption	P30D
CY2022	us-gaap	Interest Expense InterestExpense	6339000
CY2021	us-gaap	Interest Expense InterestExpense	5261000
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1257366000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1150981000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1074751000
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	673494000
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	631882000
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	589418000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	94411000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	74516000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	48454000
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	57593000
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	56806000
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	56145000
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.64
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.31
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.86
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	57593000
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	56806000
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	56145000
CY2023	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	763000
CY2022	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	865000
CY2021	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1214000
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	58356000
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	57671000
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	57359000
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.62
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.29
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.84
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1143000
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1438000
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	799000
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	21333000
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	18042000
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	16090000
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	23300000
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	27110000
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	36086000
CY2023	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	14503000
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	18952000
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	20194000
CY2023	us-gaap	Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions	3001000
CY2022	us-gaap	Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions	3423000
CY2021	us-gaap	Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions	5571000
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3077000
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	49.62
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	444000
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	72.36
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	606000
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	33.48
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	47000
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	60.08
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2868000
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	56.39
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y5M8D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	56333000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	94411000
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1714000
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	50.73
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P2Y4M24D
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	43234000
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	2868000
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	56.39
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P3Y5M8D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	56333000
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	383523000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	382976000
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	371658000
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1257366000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1150981000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1074751000
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	123944000
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	87563000
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	60916000
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-11855000
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-4934000
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-6999000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	17678000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	8113000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5463000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	74516000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	48454000
CY2023Q4	us-gaap	Assets Assets	2325244000
CY2022Q4	us-gaap	Assets Assets	1663966000
CY2021Q4	us-gaap	Assets Assets	1648294000
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	89985000
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	81804000
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	84066000
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	34290000
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	45029000
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	27939000
CY2023	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	8800000
CY2022	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	7700000
CY2021	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	6500000
CY2023	us-gaap	Payment For Contingent Consideration Liability Operating Activities PaymentForContingentConsiderationLiabilityOperatingActivities	12800000
CY2022	us-gaap	Payment For Contingent Consideration Liability Operating Activities PaymentForContingentConsiderationLiabilityOperatingActivities	1800000
CY2023	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0.0
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	1700000
CY2021	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	1600000
CY2021	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	1400000
CY2022	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	0
CY2023	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	0
CY2022	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2023	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2022	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	0
CY2023	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	0
CY2023Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	19100000
CY2022Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	15600000
CY2021	us-gaap	Lease Cost LeaseCost	15938000
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	13804000
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	281000
CY2021Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	199000
CY2023	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	287000
CY2022	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	82000
CY2023Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	568000
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	281000
CY2023Q4	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P15Y
CY2023	mmsi	Lessee Operating Lease Termination Period LesseeOperatingLeaseTerminationPeriod	P1Y
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	63047000
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	65262000
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	12087000
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	11005000
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	56259000
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	59736000
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	68346000
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	70741000
CY2023	us-gaap	Lease Cost LeaseCost	14400000
CY2022	us-gaap	Lease Cost LeaseCost	13800000
CY2021	us-gaap	Lease Cost LeaseCost	15900000
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	14879000
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	14219000
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	16013000
CY2023	us-gaap	Sublease Income SubleaseIncome	488000
CY2022	us-gaap	Sublease Income SubleaseIncome	409000
CY2021	us-gaap	Sublease Income SubleaseIncome	75000
CY2023	us-gaap	Lease Cost LeaseCost	14391000
CY2022	us-gaap	Lease Cost LeaseCost	13810000
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	13710000
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	14970000
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	8891000
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	11130000
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1524000
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P9Y7M6D
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P10Y4M24D
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P11Y4M24D
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.034
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.034
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.034
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	13706000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	10718000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	8867000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	7432000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	6089000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	33950000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	80762000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	12416000
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	68346000
CY2023Q4	mmsi	Lessee Operating Lease Lease Not Yet Commenced Average Annual Maturities LesseeOperatingLeaseLeaseNotYetCommencedAverageAnnualMaturities	700000
CY2023Q4	us-gaap	Lessee Operating Lease Lease Not Yet Commenced Term Of Contract1 LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1	P11Y
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023	dei	Auditor Firm AuditorFirmId	34

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0000856982-24-000015-index-headers.html	Edgar Link	pending
0000856982-24-000015-index.html	Edgar Link	pending
0000856982-24-000015.txt	Edgar Link	pending
0000856982-24-000015-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
mmsi-20231231.xsd	Edgar Link	pending
mmsi-20231231x10k.htm	Edgar Link	pending
mmsi-20231231x10k001.jpg	Edgar Link	pending
mmsi-20231231x10k002.jpg	Edgar Link	pending
mmsi-20231231xex10d68.htm	Edgar Link	pending
mmsi-20231231xex10d68g001.jpg	Edgar Link	pending
mmsi-20231231xex10d68g002.jpg	Edgar Link	pending
mmsi-20231231xex10d68g003.jpg	Edgar Link	pending
mmsi-20231231xex10d68g004.jpg	Edgar Link	pending
mmsi-20231231xex10d68g005.jpg	Edgar Link	pending
mmsi-20231231xex10d68g006.jpg	Edgar Link	pending
mmsi-20231231xex10d68g007.jpg	Edgar Link	pending
mmsi-20231231xex10d68g008.jpg	Edgar Link	pending
mmsi-20231231xex10d68g009.jpg	Edgar Link	pending
mmsi-20231231xex10d68g010.jpg	Edgar Link	pending
mmsi-20231231xex10d68g011.jpg	Edgar Link	pending
mmsi-20231231xex10d68g012.jpg	Edgar Link	pending
mmsi-20231231xex10d68g013.jpg	Edgar Link	pending
mmsi-20231231xex10d68g014.jpg	Edgar Link	pending
mmsi-20231231xex10d68g015.jpg	Edgar Link	pending
mmsi-20231231xex10d68g016.jpg	Edgar Link	pending
mmsi-20231231xex10d68g017.jpg	Edgar Link	pending
mmsi-20231231xex10d68g018.jpg	Edgar Link	pending
mmsi-20231231xex10d68g019.jpg	Edgar Link	pending
mmsi-20231231xex10d68g020.jpg	Edgar Link	pending
mmsi-20231231xex10d68g021.jpg	Edgar Link	pending
mmsi-20231231xex10d68g022.jpg	Edgar Link	pending
mmsi-20231231xex10d68g023.jpg	Edgar Link	pending
mmsi-20231231xex10d68g024.jpg	Edgar Link	pending
mmsi-20231231xex10d68g025.jpg	Edgar Link	pending
mmsi-20231231xex10d68g026.jpg	Edgar Link	pending
mmsi-20231231xex10d68g027.jpg	Edgar Link	pending
mmsi-20231231xex10d68g028.jpg	Edgar Link	pending
mmsi-20231231xex10d68g029.jpg	Edgar Link	pending
mmsi-20231231xex10d68g030.jpg	Edgar Link	pending
mmsi-20231231xex10d68g031.jpg	Edgar Link	pending
mmsi-20231231xex10d68g032.jpg	Edgar Link	pending
mmsi-20231231xex10d68g033.jpg	Edgar Link	pending
mmsi-20231231xex10d69.htm	Edgar Link	pending
mmsi-20231231xex10d69g001.jpg	Edgar Link	pending
mmsi-20231231x10k_htm.xml	Edgar Link	completed
mmsi-20231231xex10d69g002.jpg	Edgar Link	pending
mmsi-20231231xex10d69g003.jpg	Edgar Link	pending
mmsi-20231231xex10d69g004.jpg	Edgar Link	pending
mmsi-20231231xex10d69g005.jpg	Edgar Link	pending
mmsi-20231231xex10d69g006.jpg	Edgar Link	pending
mmsi-20231231xex10d69g007.jpg	Edgar Link	pending
mmsi-20231231xex10d69g008.jpg	Edgar Link	pending
mmsi-20231231xex10d69g009.jpg	Edgar Link	pending
mmsi-20231231xex10d69g010.jpg	Edgar Link	pending
mmsi-20231231xex10d69g011.jpg	Edgar Link	pending
mmsi-20231231xex10d69g012.jpg	Edgar Link	pending
mmsi-20231231xex10d69g013.jpg	Edgar Link	pending
mmsi-20231231xex10d69g014.jpg	Edgar Link	pending
mmsi-20231231xex10d69g015.jpg	Edgar Link	pending
mmsi-20231231xex10d69g016.jpg	Edgar Link	pending
mmsi-20231231xex10d69g017.jpg	Edgar Link	pending
mmsi-20231231xex10d69g018.jpg	Edgar Link	pending
mmsi-20231231xex10d69g019.jpg	Edgar Link	pending
mmsi-20231231xex10d69g020.jpg	Edgar Link	pending
mmsi-20231231xex10d69g021.jpg	Edgar Link	pending
mmsi-20231231xex10d69g022.jpg	Edgar Link	pending
mmsi-20231231xex10d69g023.jpg	Edgar Link	pending
mmsi-20231231xex10d69g024.jpg	Edgar Link	pending
mmsi-20231231xex10d69g025.jpg	Edgar Link	pending
mmsi-20231231xex21.htm	Edgar Link	pending
mmsi-20231231xex23d1.htm	Edgar Link	pending
mmsi-20231231xex31d1.htm	Edgar Link	pending
mmsi-20231231xex31d2.htm	Edgar Link	pending
mmsi-20231231xex32d1.htm	Edgar Link	pending
mmsi-20231231xex32d2.htm	Edgar Link	pending
mmsi-20231231xex4d2.htm	Edgar Link	pending
mmsi-20231231xex97.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R108.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
mmsi-20231231_lab.xml	Edgar Link	unprocessable
mmsi-20231231_pre.xml	Edgar Link	unprocessable
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
mmsi-20231231_cal.xml	Edgar Link	unprocessable
mmsi-20231231_def.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MMSI
MERIT MEDICAL SYSTEMS INC Stock $mmsi

2024 Q1 Form 10-K Financial Statement

#000085698224000015 Filed on February 28, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MMSI MERIT MEDICAL SYSTEMS INC Stock $mmsi

2024 Q1 Form 10-K Financial Statement

#000085698224000015 Filed on February 28, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MMSI
MERIT MEDICAL SYSTEMS INC Stock $mmsi